No abstract

Gold nanoparticles are considered the newest drug carriers for different diseases. Therefore it is appropriate continuous optimization of their preparation. In this study, gold colloids with an average size of 1 -26 nm were obtained by the reduction of tetrachloroauric acid with trisodium citrate. The nanomaterials were characterized by UV-Vis spectroscopy and dynamic light scattering technique. In addition, zeta potential was measured for samples synthesized in order to determine the stability of the colloids. A Two-level Full Factorial design was chosen to determine the optimum set of process parameters (chloroauric acid concentration and sodium citrate concentration) and their effect on various gold nanoparticles characteristics (size and zeta potential). These effects were quantified using Design of Experiments (DoE) with 5 runs and 1 centerpoint. The selected objective and process model in this investigation are screening and interaction. Findings from this research show that to obtain particles larger than 35 nm, it is recommended to increase sodium citrate concentration, at low chloroauric acid values. These conditions will help to achieve smaller zeta potential, too.

The purpose of this study was the synthesis of two types of biodegradable materials with synthetic polymers (PLGA) or natural polymers (collagen) and hydroxyapatite, followed by determination of the encapsulation percentage of the drug in the polymer. Regardless of the chosen method, the percentage of the encapsulated drug was found to be quite high: 15.92% in the Coll-HA-Genta material and 19.59% respectively in the PLGA-Genta biocomposite. The therapeutic value of gentamicin was improved by encapsulating it in delivery systems, contributing to sustained release for a long time (about 30 days).

No abstract